The PaceNew therapies / indications available since the last 12 months 
Nustendi
BY: Julia CheungOct 24, 2023

Nustendi®
 (bempedoic acid) Daiichi Sankyo

 

Composition:

• Available as film-coated tablet containing 180 mg of bempedoic acid and 10 mg of ezetimibe

 

Indication:

• As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C

You May Be Interested In
Cibinqo
BY: Winnie TangDec 18, 2023
JAYPIRCA®
BY: Dr. Feng XueDec 19, 2025
EMBLAVEO®
BY: Dr. Feng XueFeb 11, 2026
Praluent
BY: Olive TseDec 15, 2020